How I treat idiopathic patients with inflammatory myopathies in the clinical practice

Lorenzo Cavagna; Sara Monti; Roberto Caporali; Mariele Gatto; Luca Iaccarino; Andrea Doria

doi:10.1016/j.autrev.2017.07.016

How I treat idiopathic patients with inflammatory myopathies in the clinical practice

Autoimmun Rev. 2017 Oct;16(10):999-1007. doi: 10.1016/j.autrev.2017.07.016. Epub 2017 Aug 2.

Authors

Lorenzo Cavagna¹, Sara Monti², Roberto Caporali², Mariele Gatto³, Luca Iaccarino³, Andrea Doria³

Affiliations

¹ Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, 27100 Pavia, Italy. Electronic address: lorenzo.cavagna@unipv.it.
² Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, 27100 Pavia, Italy.
³ Rheumatology Unit, Department of Medicine, University of Padova, Italy.

PMID: 28778704
DOI: 10.1016/j.autrev.2017.07.016

Abstract

Management of patients with idiopathic inflammatory myopathies (IIMs) is challenging given the systemic nature of the disease, which is often complicated by potentially life-threatening manifestations and the lack of standardized treatment regimens. Aim of this review is to provide the currently available evidence for immunotherapy in the treatment of various manifestations of IIM in order to help clinicians in the daily management of these patients.

Keywords: Antisynthetase syndrome; Glucocorticoids; Idiopathic inflammatory myopathies; Immunosuppressants; Therapy.

Publication types

Review

MeSH terms

Humans
Myositis / drug therapy*